Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021
Jessica R. MacNeil(Centers for Disease Control and Prevention), Sara E. Oliver(Centers for Disease Control and Prevention), John R. Su(National Center for Emerging and Zoonotic Infectious Diseases), Danielle Moulia(Centers for Disease Control and Prevention), Julia W. Gargano(Canadian Institutes of Health Research), Stephen C. Hadler(The Task Force for Global Health), José R. Romero(Boston University), Karen R. Broder(Centers for Disease Control and Prevention), Megan Wallace(Centers for Disease Control and Prevention), Grace M. Lee, Heather M. Scobie, Amy Blain, H. Keipp Talbot(Marshfield Clinic), Beth P. Bell(Centers for Disease Control and Prevention), Alice Guh(Adventist HealthCare Rehabilitation), Veronica V. McNally, Matthew F. Daley(Kaiser Permanente)
Cited by 187
Related Papers
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|2.4k
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
|The Lancet|2019|1.3k
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
|MMWR Morbidity and Mortality Weekly Report|2019|996
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014
|MMWR Morbidity and Mortality Weekly Report|2015|835
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720